Calistoga Pharma Raises Series A

Calistoga Pharmaceuticals, a Seattle-based drug development startup focused on oncology and inflammation, has raised $21 million in Series A funding. Frazier Healthcare Ventures led the deal, and had originally helped the company spin out of a drug development program within ICOS Corp. Other deal participants included Alta Partners, Three Arch Partners and Amgen Ventures.